Alivus Life

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE03Q201024
  • NSEID: ALIVUS
  • BSEID: 543322
INR
1,431.10
44.05 (3.18%)
BSENSE

Sep 18, 03:30 PM

BSE+NSE Vol: 4.16 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003513,
    "name": "Alivus Life",
    "stock_name": "Alivus Life",
    "full_name": "Alivus Life Sciences Ltd",
    "name_url": "stocks-analysis/alivus-life",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,431.10",
    "chg": 44.05,
    "chgp": "3.18%",
    "dir": 1,
    "prev_price": "1,387.05",
    "mcapval": "17,457.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543322,
    "symbol": "ALIVUS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE03Q201024",
    "curr_date": "Sep 18, 03:30 PM",
    "curr_time": "03:20 AM",
    "last_traded_at": "Sep 18, 03:30 PM IST",
    "bse_nse_vol": "4.16 lacs",
    "exc_status": "Active",
    "traded_date": "Sep 18, 2026",
    "traded_date_str": "2026 09 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alivus-life-1003513-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Alivus Life Sciences Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-sciences-ltd-is-rated-hold-4186250",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AlivusLifeScien_mojoScore_4186250.png",
        "date": "2026-09-08 10:11:17",
        "description": "Alivus Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 04 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 September 2026, providing investors with an up-to-date view of the company's performance and outlook."
      },
      {
        "title": "Why is Alivus Life Sciences Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-alivus-life-sciences-ltd-fallingrising-4182925",
        "imagepath": "",
        "date": "2026-09-05 01:51:13",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Intraday Price Movement and Trading Activity</strong></p>\n<p>During the trading session on 04-Sep, Alivus Life Sciences touched an intraday low of ₹1,363.50, representing a 3.88% decrease from previous levels. The weighted average price indicates that a greater volume of shares traded closer to this lower price point, suggesting selling pressure dominated the session. Despite this, the stock remains well above its 50-day, 100-day, and 200-day moving averages, signalling that the broader trend remains positive. However, it is currently trading below its 5-day and 20-day moving averages, which may reflect short-term weakness or profit-taking by investors.</p>\n<p>Investor participation also declined significantly, with delivery volume on 03-Sep falling by 71.81% compared to the five-day average..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Alivus Life Sciences Ltd to 52-Week High of Rs 1495.3",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-hits-new-52-week-high-at-rs14953-4175684",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlivusLifeScien_priceRelatedfactors_4175684.png",
        "date": "2026-08-31 09:54:58",
        "description": "With a decisive intraday surge to Rs 1495.3 on 31 Aug 2026, Alivus Life Sciences Ltd has reached a fresh 52-week and all-time high, extending its impressive 50.28% gain over the past year despite a broadly weakening market backdrop."
      },
      {
        "title": "Alivus Life Sciences Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-sciences-ltd-is-rated-hold-4171350",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlivusLifeScien_mojoScore_4171350.png",
        "date": "2026-08-27 10:11:02",
        "description": "Alivus Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 04 August 2026. The analysis and financial metrics discussed here reflect the stock's current position as of 27 August 2026, providing investors with an up-to-date view of its performance and outlook."
      },
      {
        "title": "Alivus Life Sciences Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alivus-life-sciences-ltd-is-rated-hold-4156238",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlivusLifeScien_mojoScore_4156238.png",
        "date": "2026-08-16 10:10:41",
        "description": "Alivus Life Sciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 4 August 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 16 August 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and market performance."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Alivus Life Sciences Ltd to 52-Week High of Rs 1415.9",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-hits-new-52-week-high-at-rs14159-4147239",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlivusLifeScien_priceRelatedfactors_4147239.png",
        "date": "2026-08-11 10:01:40",
        "description": "Surging past its previous peaks, Alivus Life Sciences Ltd reached a fresh 52-week high of Rs 1415.9 on 11 Jun 2026, marking a remarkable 51.09% gain over the past year. This milestone comes amid a backdrop of strong technical momentum, with the stock outperforming its sector and the broader market despite a subdued Sensex."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Alivus Life Sciences Ltd to 52-Week High of Rs 1385.45",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-hits-new-52-week-high-at-rs138545-4145468",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlivusLifeScien_priceRelatedfactors_4145468.png",
        "date": "2026-08-10 10:16:47",
        "description": "With every major technical indicator aligned to the upside, Alivus Life Sciences Ltd surged to a fresh 52-week high of Rs 1385.45 on 10 Jun 2026, marking a significant milestone in its price momentum journey."
      },
      {
        "title": "Alivus Life Sciences Gains 14.59%: 7 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-gains-1459-7-key-factors-driving-the-weeks-momentum-4143076",
        "imagepath": "",
        "date": "2026-08-08 12:02:29",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>3 Aug:</strong> New 52-week high at Rs.1,223.60</p>\n                    <p><strong>4 Aug:</strong> Intraday high surge to Rs.1,310 and Mojo Score upgrade</p>\n                    <p><strong>5 Aug:</strong> Downgrade to Hold amid valuation concerns</p>\n                    <p><strong>6 Aug:</strong> New 52-week high at Rs.1,361.95</p>\n                    <p><strong>7 Aug:</strong> Week closes at Rs.1,328.30 (+0.52%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,211.80</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Cl..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Alivus Life Sciences Ltd to 52-Week High of Rs 1361.95",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alivus-life-sciences-ltd-hits-new-52-week-high-at-rs136195-4139993",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlivusLifeScien_priceRelatedfactors_4139993.png",
        "date": "2026-08-06 10:21:59",
        "description": "With a decisive surge to Rs 1361.95 on 6 Jun 2026, Alivus Life Sciences Ltd has reached a new 52-week and all-time high, marking a 43.4% gain over the past year. This rally stands out amid a broadly positive market backdrop, driven by a confluence of strong technical signals across multiple timeframes."
      }
    ],
    "total": 335,
    "sid": "1003513",
    "stock_news_url": "https://www.marketsmojo.com/news/alivus-life-sciences-1003513"
  },
  "announcements": [
    {
      "caption": "The Company Has Incorporated A Wholly Owned Subsidiary Company In Brazil.",
      "datetime": "16-Sep-2026",
      "details": "Please find enclosed herewith intimation with respect to incorporation of wholly owned subsidiary of the Company in Brazil.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "11-Sep-2026",
      "details": "Enclosed please find herewith details of Investor meet.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
      "datetime": "08-Sep-2026",
      "details": "Please find attached herewith proceedings of the 15th Annual General Meeting of Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) held on 8th September 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alivus Life Sciences Ltd has declared <strong>250%</strong> dividend, ex-date: 01 Sep 26",
          "dt": "2026-09-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Why is Alivus Life Sciences Ltd falling/rising?

2026-09-05 01:51:13

Intraday Price Movement and Trading Activity

During the trading session on 04-Sep, Alivus Life Sciences touched an intraday low of ₹1,363.50, representing a 3.88% decrease from previous levels. The weighted average price indicates that a greater volume of shares traded closer to this lower price point, suggesting selling pressure dominated the session. Despite this, the stock remains well above its 50-day, 100-day, and 200-day moving averages, signalling that the broader trend remains positive. However, it is currently trading below its 5-day and 20-day moving averages, which may reflect short-term weakness or profit-taking by investors.

Investor participation also declined significantly, with delivery volume on 03-Sep falling by 71.81% compared to the five-day average...

Read full news article
stock-recommendationAnnouncement

The Company Has Incorporated A Wholly Owned Subsidiary Company In Brazil.

16-Sep-2026 | Source : BSE

Please find enclosed herewith intimation with respect to incorporation of wholly owned subsidiary of the Company in Brazil.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

11-Sep-2026 | Source : BSE

Enclosed please find herewith details of Investor meet.

Shareholder Meeting / Postal Ballot-Outcome of AGM

08-Sep-2026 | Source : BSE

Please find attached herewith proceedings of the 15th Annual General Meeting of Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) held on 8th September 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Alivus Life Sciences Ltd has declared 250% dividend, ex-date: 01 Sep 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available